Cromer, M. Kyle http://orcid.org/0000-0002-8198-5010
Barsan, Valentin V.
Jaeger, Erich http://orcid.org/0000-0003-4734-6060
Wang, Mengchi
Hampton, Jessica P. http://orcid.org/0000-0002-0084-5404
Chen, Feng
Kennedy, Drew
Xiao, Jenny
Khrebtukova, Irina
Granat, Ana
Truong, Tiffany http://orcid.org/0000-0002-8327-399X
Porteus, Matthew H. http://orcid.org/0000-0002-3850-4648
Article History
Received: 17 December 2021
Accepted: 22 July 2022
First Online: 11 August 2022
Competing interests
: The authors of this study declare the following competing interests: M.H.P. is on the Board of Directors of Graphite Bio. M.H.P. serves on the SAB of Allogene Tx and is an advisor to Versant Ventures. M.H.P., M.K.C., and V.V.B. hold equity in Graphite Bio. V.V.B. serves on the Board of Directors and SAB of Umoja Biopharma, the Board of Directors of ArsenalBio, and is a board observer at Synthego. M.H.P. holds equity in CRISPR Tx. E.J., M.W., F.C., I.K., A. G., and T.T. are employees of Illumina, Inc. The remaining authors declare no competing interests.